Albany, NY -- (SBWIRE) -- 05/20/2014 -- THE PHARMACEUTICAL MARKET: CANADA - REVIEW

The relatively high consumption of patented drugs in Canada in comparison with other developed countries remains a positive sign for multinational pharmaceutical companies to maintain their current sales level s by 201 7 . Although innovative drugmakers have also experienced government cost containment policies and the patent cliff in Canada, the negative impact of these phenomena is less extreme than that in many other developed countries. The average cost of generic drugs per prescription experienced its first decline in Canada during 2011, indicating that a more competitive environment for generic drugmakers has been formed, which will ultimately benefit consumers .

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/the-pharmaceutical-market-canada

HeadlineExpenditureProjections

Pharmaceuticals: CAD25.81bn (US$26.06bn) in 2011 to CAD25.64bn (US$25.64bn) in 2012; -0.5% growth in local currency terms and -1.6% growth in US dollar terms. ForecastdownwardfromQ412on account oflower than expected new industry data.
MedicalDevices: CAD6.83bn (US$6.91bn) in 2011 to CAD7.12bn (US$7.12bn) in 2012; +4.2% growth in local currency terms and +3.1% growth in US dollar terms. Forecastslightly up fromQ412due to new industry data.

Risk/RewardRating

The attractiveness of the Americas to multinational pharmaceuticals has declined moderately in BMI's RRRs for Q113. The average score for the region increased from 49.2 in Q412 to 49.4 in Q113. The Americas region continues to rank second-lowest globally with a score of 49.4 out of 100, behind Western Europe (66), Asia Pacific (53) and Central and Eastern Europe (51), but ahead of the Middle East and Africa (44).

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/198480

Competitive Landscape

The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

Table of Contents

BMI Industry View7
SWOT9
Political11
Economic12
Industry Forecast13
Pharmaceutical Market Forecast13

Table: Canada Pharmaceutical Sales, Historical Data and Forecasts14

To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/198480

Healthcare Market Forecast15

Table: Healthcare Expenditure Trends, Historical Data and Forecasts16
Table: Government Healthcare Expenditure Trends, Historical Data and Forecasts16
Table: Private Healthcare Expenditure Trends, Historical Data and Forecasts17

Macroeconomic Forecast18

Table: Canada - Gdp By Expenditure, Real Growth %20

Prescription Drug Market Forecast24

Table: Prescription Drug Market Indicators, Historical Data and Forecasts25

Patented Drug Market Forecast26

Table: Patented Drug Market Indicators, Historical Data and Forecasts27

Generic Drug Market Forecast28

Table: Generics Drug Market Indicators, Historical Data and Forecasts30

About Marketresearchreports.biz
Marketresearchreports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact US:
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz